Biobanks & neurodegenerative diseases

In this episode, Alice Limonciel and Karel Kalecký discuss what to look out for when planning a metabolomics experiment with brain tissue samples from biobanks, what characterizes Parkinson’s and Alzheimer’s disease at the metabolic level, and his experience navigating biological interpretation as a computer scientist turned metabolomist.

Karel Kalecký

Karel Kalecký is postdoctoral research associate
at the Institute of Metabolic Disease, Baylor Scott & White Research Institute in Dallas, TX (USA)

Favorite metabolite
Betaine (trimethylglycine)

Papers we discussed in this episode
One-Carbon Metabolism in Alzheimer’s Disease and Parkinson’s Disease Brain Tissue
Targeted Metabolomic Analysis in Alzheimer’s Disease Plasma and Brain Tissue in Non-Hispanic Whites

Sign up for The Metabolomist mailing list to be the first to hear about the latest episodes and news around metabolomics at

Finally available – Alices first book
The STORY principle – A guide to the biological interpretation of metabolomics
Also featuring some of the Metabolomists from Season 1
Available on Amazon and the biocrates webshop